Introduction to bleeding disorders. Flashcards

1
Q

In haemostatic balance what 2 factors are balance

A

bleeding (anti-coagulant)

clotting (procoagulant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the first step which results in the activation of a haemostatic plug forming

A

disruption to the BV wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what molecule do platelets adhere to

A

vWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what molecule does vWF attach to

A

collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what molecule does thrombin activate

A

fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where does thromboxane synthesis take place

A

inside the platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the purpose of thromboxane

A

contacts blood vessels and activates platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 important receptors found on the plasma membrane of a platelet.

A

IIaIIIA- receptor for fibrinogen= platelet aggregation.

IBIX- receptor for vWF=platelet adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

aspirin inhibits cycloxygenase, what is the function of cycloxygenase

A

produce thromboxane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what molecule does clopidogrel inhibit

A

ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what happens in the extrinsic pathway.

A
  1. Tissue factor expressed on injurged cells= damage BV

2. Activates VII-VIIa, this activates X- Xa, this activated prothrombin to thrombin which converts fibrinogen to fibrin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens in the intrinsic pathway

A
  1. XIIa-XIIa, which converts XI-XIa, which converts IX-IXa.

2. activates X- Xa, this activated prothrombin to thrombin which converts fibrinogen to fibrin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the procoagulant molecules.

A

platelets

clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the anticoagulant molecules

A

Protein C
Protein S- co factor protein C.
Anti-thrombin III
Fibrinolytic system- breaks down the clot when it is no longer needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the fibrinolytic pathway

A

Tissue plasminogen factor (TPA) breakdown plasminogen to plasmin.
Plasmin then converts fibrin into a fibrin degradation product.
This happens on the surface of a clot.
TPA use for clot busting in acute MI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different types of bleeding disorders

A
congenital
acquired
platelet
vessel wall
coagulation defect
17
Q

What drug can cause abnormal platelet function (Blood thinner)

18
Q

what condition is caused by abnormal interaction between the vessel wall and platelets

A

von willibrand factor.

19
Q

what are the major difference between platelet and coagulation defects

A

platelet defects- affect skin and mucosal membranes and form petichae and bruising on skin
coagulation defects- affect spreading haematoma and haemoarthrosis, affect retroperrtioneal bleeding which is often recurrent and prolonged.

20
Q

do petichae blache when pressure is applied

21
Q

Von Willebrand disease is caused by a deficiency in which molecule

22
Q

what type of genetic disorder is von willebrand factor

A

autosomal dominant.

23
Q

what factor is reduced in von willebrand disease

A

factor 8 (FVIII)

24
Q

which blood group has lower levels of von willebrand factor

A

blood group O

25
what are common consequences of von willebrand disease
* Mucocutaneous bleeding including menorrhagia | * Postoperative and post partum bleeding
26
are there different types of von willebrand factor, in terms of disease.
yes there are mild and more severe forms.
27
what is the treatment that is provided for von willebrand factor disease
Antifibrinolytics: tranexamic acid (important in mouth bleeds) DDAVP- releases VWF from stores in endothelial cells. factor concentrates of VWF vaccination against hepatitis COCP (combined oral contraceptive pill) for menorrhagia
28
haemophilllia a is a deficnecy in which factor
factor VII
29
haemophillia b is a deficnency in whihc factor
factor IX.
30
what type of genetic inherited disorder are the haemophillias
x-linked.
31
what is the function of the drug DDAVP
release vWF form endothelial cells.
32
are there degrees of severity in haemophilia
yes | normal, mild, moderate and severe.
33
what are the different types of bleeds occur in haemophilia
``` spontaneous/post traumatic joint bleeding- haemarthorosis. muscle- haemorrhage soft tissue- mouth bleed and intracranial bleed. life threatening bleed in the airways. ```
34
what is acute and chronic haemophilic arthropathy- which is a complication of haemophilia
swollen bone deformity | muscle wasting
35
treatment for haemophilia
``` Replacement of missing clotting protein DDAVP factor concentrates antifibrinolytic agents vaccine for hep A and hep B ```
36
complications of treatment from haemophilia treatment
Infections- Hep A,B,C,G, HIV, paravirus, vCJD. Inhibitor development (more common in haemophilia A)- patients become resistant to replacement therapy.
37
How is haemophilia managed
Haemophilia Centres and Comprehensive care Centres. Multidisciplinary Approach Home treatment Patient Education and Social Support Physiotherapy Orthopaedic Advice & Treatment Treatment & Diagnosis of Liver Disease Specialised Management for HIV Positive Patients Genetic Counselling & Parental Diagnosis
38
appropriate investigations if you suspect a bleeding disorder.
``` Full blood count and blood film Coagulation screen Mixing studies if abnormal results Refer to a haematologist if history suspicious Von Willebrand profile platelet function tests ```
39
what conditions does the bleeding /normal coagulation screen show.
```  Thrombocytopenia  Disorder of platelet function  vWD  Factor XIII deficiency  Mild coagulation factor deficiency  Vascular disorder  Disorder of fibrinolysis: rare ```